Company Overview

AtriCure, Inc. is a medical device company that provides innovative solutions designed to decrease the global atrial fibrillation epidemic.  AtriCure’s Isolator® Synergy™ Ablation System is the first and only surgical device approved for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. AtriCure’s AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.

Company Summary
AtriCure, Inc.
Number of Employees
500 or more
(513) 755-4100
7555 Innovation Way
Mason, OH
 This company is a Federal Contractor